Showing results (261-270 of 300) with videos related to

Sort By:
Pageof 30
Frontiers in Physiology|February 27, 2019
Beta 3 Adrenergic Receptor Activation Rescues Metabolic Dysfunction in Female Estrogen Receptor Alpha-Null MiceStephanie L Clookey, Rebecca J Welly, Dusti Shay, et al.
International Immunopharmacology|November 21, 2015
Unveiling the anti-inflammatory activity of Sutherlandia frutescens using murine macrophagesWei Lei, Jimmy D Browning, Peggy A Eichen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 5, 2015
Evaluation of the effect of tofacitinib exposure on outcomes in kidney transplant patientsF Vincenti, H T Silva, S Busque, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 19, 2017
Docosahexaenoic acid (DHA): An essential nutrient and a nutraceutical for brain health and diseasesGrace Y Sun, Agnes Simonyi, Kevin L Fritsche, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 29, 2016
Gestational diabetes alters the fetal heart rate variability during an oral glucose tolerance test: a fetal magnetocardiography studyE Fehlert, K Willmann, L Fritsche, et al.
Journal of Nutrition and Metabolism|September 16, 2011
Exercise and Omega-3 Polyunsaturated Fatty Acid Supplementation for the Treatment of Hepatic Steatosis in Hyperphagic OLETF RatsSarah J Borengasser, R Scott Rector, Grace M Uptergrove, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 11, 2013
Sotrastaurin in calcineurin inhibitor-free regimen using everolimus in de novo kidney transplant recipientsH Tedesco-Silva, M M L Kho, A Hartmann, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 19, 2014
Five-year outcomes in kidney transplant patients converted from cyclosporine to everolimus: the randomized ZEUS studyK Budde, F Lehner, C Sommerer, et al.
Pageof 30